Topical Treatments for Eczema (Series 9)

This activity is supported by independent educational grants from Pfizer, Sanofi Genzyme and Regeneron Pharmaceuticals, and Incyte.

Part of a 16-course series, this activity is designed to provide licensed practitioners from medical, nursing, and related disciplines with an understanding of the basic principles of managing patients with eczema in the 21st century. The program will cover current concepts in etiology, diagnosis, and management of atopic dermatitis (AD) in children and adults. 

Target Audience
This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with AD.

9. Schmear It On - New Paradigms in Topical Treatments for Eczema
The FDA recently approved a new topical medication for the treatment of eczema. How does this new development change daily practice? This class will review the biological principle of inhibiting phosphodiesterase as an anti-inflammatory strategy and consider how this therapy may be integrated into the daily eczema regimen.

Educational Objectives

After completing this activity, participants will be able to:

• Review the basics of topical agents available for eczema treatment
• Explore phosphodiesterase inhibition for eczema treatment
• Integrate various topicals into a coherent patient regimen

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and LearnHealth. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This CE activity provides 0.75 contact hours of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299 for 0.75 contact hours.

Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period March 19, 2018 through December 11, 2021 participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.

Media
Internet

Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, LearnHealth, and/or Pfizer, Sanofi Genzyme and Regeneron Pharmaceuticals, and Incyte. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

This activity is jointly provided by Medical Education Resources and LearnHealth Inc.

For questions regarding accreditation, please contact MER at 800-421-3756. For all other questions, please contact [email protected].

This activity is subject to MER's Privacy Policy and LearnSkin's Terms of Use.